Future frontiers in AML: the five key therapy pillars & the future of trials
How should MRD be used for MM in routine clinical practice?
Better survival outcomes with the use of new CLL drugs
Overview of the RATIFY study: midostaurin combination therapy for AML
Exciting new treatments in myeloma